Xarelto Lawsuit Helpline
Get An Xarelto Extensive Bleeding LawyerIf you or a loved one took Xarelto for prevention of blood clots and pulmonary embolisms and this resulted in severe injury or death contact Xarelto Lawsuit Helpline. Xarelto lawyers file Xarelto lawsuits of behalf of victims and their family. They allege that the drug makers failed to properly inform you about severe and life-threatening bleeding risks associated with the drug Xarelto.
Why File An Xarelto LawsuitXarelto lawsuits are consolidated lawsuits for people who have suffered serious health complications after using this prescription anticoagulant. Lawsuits have been filed against drug makers Bayer Healthcare and Johnson & Johnson. These lawsuits claim that the drug manufacturers failed to properly inform you about serious and potentially life-threatening risks associated with Xarelto.
- internal bleeding,
- gastrointestinal bleeding
- Brain bleeding
- other severe bleeding events.
Blood Clot Help Turns To Danger
Drugs For Blood Clot Prevention- Blood Thinners- DangerousXarelto Excessive Bleeding Lawsuits
Blood Clot Capture Surgical Implant- DangerousBard IVC Filter Lawsuits Cook IVC Filter Lawsuits
Blood Thinners and Blood Clot Capture DevicesPadaxa and Xarelto are both blood thinners with warnings and lawsuits for excessive bleeding and fatalities. The Bard and Cook Inferior Vena Cava filters solve the problem of blood clots traveling to the heart and lungs in another way.
IVC FiltersThe Bard and Cook Vena Cava filters are surgical implants that capture the blood clots as the move to the heart or lungs. These are not without their complications and side effects. The filter can fragment and pieces can migrate causing severe damage to internal organs, Bard and Cook Inferior Vena Cava- IVC filters have been the focus of many attorney T.V ads and lawsuits.
IVC Filter OverviewThe FDA issued a warning letter to Bard in July 2015 for illegally marketing a device used to remove the Recovery IVC filter, as well as for problems with its Denali IVC filter. In October 2014, all Cook Medical IVC filter lawsuits were centralized as part of an MDL in U.S. District Court for the Southern District of Indiana for pretrial proceedings. In August 2015, federal judges centralized lawsuits involving C.R. Bard IVC filters into a Multi-District Litigation (MDL No. 2641) in Arizona under U.S. District .
IVC Lawsuits Are Being Filed For:
C.R. Bard IVC Filter LawysuitsRecovery IVC Filter (withdrawn in 2005) G2 IVC Filter G2 Express / G2X Filter Eclipse Meridian Denali
Cook IVC Filter LawsuitsGünther Tulip Celect
If you have been injured by a Bard or Cook IVC filter Contact Us Today
Bard IVC Filter HelplineThe Bard IVC Filter Helpline has just found out from our IVC Filter lawyers that the IVC blood clot capture filter lawsuits are increasing. NBC News has just televised a news report about the safety issues associated with the G2 Retrievable IVC Filter. Tje IVC Filter is a blood clot filter marketed by C.R. Bard, Inc. IVC filters, such as the G2 and Recovery filters , are used to prevent pulmonary embolism in patients for whom anticoagulant medications are not appropriate. These wire implants are placed in in the inferior vena cava. This is the body’s largest blood vessel. They catch blood clots before they can travel to the heart and lungs.
IVC Filter InjuryThe Recovery IVC filter had been associated with more than 300 non-fatal injuries and 27 deaths before it was replaced with the G2 series. Among other things, the report disclosed a confidential study commissioned by Bard in 2004 which linked the Recovery IVC filter to higher rates of death, fracture and movement compared to its competitors. Like the G2, Bard opted not to recall the Recovery filter, and instead allowed it to remain on the market for three years. Roughly 34,000 devices were sold.
IVC Filter LawsuitsCourt records indicate that at least 72 Bard IVC filter lawsuits involving the G2 and Recovery products are now pending in a multidistrict litigation underway in the U.S. District Court, District of Arizona. Among other things, plaintiffs claim that Bard was aware that the Recovery and G2 IVC filters were associated with high rates of fracture, migration and tilting, which may result in perforation of the inferior vena cava, embolization and other life-threatening complications. (In Re: Bard IVC Filters Products Liability Litigation – MDL No. 2641)
Get An IVC Filter LawyerContact the Bard IVC Filter Helpline to learn about your rights in joining the IVC Filter Multi District Litigation.
The Pradaxa Helpline has Launched An Xarelto Helpline For Injured VictimsXarelto Extensive Bleeding Complications Did you or a loved one take Xarelto and develop uncontrolled bleeding? Complications Include:
- Internal hemorrhaging
- Brain bleeding
- Gastrointestinal bleeding
- Excessive and uncontrollable bleeding
FDA Warning Issued For XareltoJanuary 2014 Summary View 5 WARNINGS AND PRECAUTIONS 5.2 Risk of Bleeding Promptly evaluate any signs or symptoms of blood loss and consider the need for blood replacement. Reversal of Anticoagulant Effect: A specific antidote for rivaroxaban is not available.
Xarelto Lawyers Filing LawsuitsXarelto Lawsuits For Excessive Bleeding The Xarelto Helpline lawyers are accepting lawsuits against the makers of Xarelto. Xarelto has been linked to serious injuries and death from irreversible bleeding.
About XareltoXarelto is a blood thinner medication manufactured by Bayer Pharmaceuticals and marketed by Johnson & Johnson. It was approved by the FDA in 2011 to prevent deep vein thrombosis (DVT) in patients undergoing hip or knee replacement surgery. Xarelto was also y the FDA to prevent stroke in patients with an abnormal atrial fibrillation. Xarelto is like Pradaxa.
Xarelto Injury LawyersOur Xarelto extensive bleeding lawyers are seeking victims who have suffered from serious bleeding, internal hemorrhaging, heart attack, stroke, or died while taking Xarelto.
Actos Bladder Cancer Lawsuit HelplineDo you have a family member who is type II diabetic ( adult onset )? Have they been on Actos? Are they now diagnosed with Bladder cancer? Lawyers are filing bladder cancer lawsuits for victims of Actos bladder cancer. family members have been calling the Actos Helpine seeking advise and direction. We will be seeing thousands or more people affected over the coming year as they become aware of the warning and start showing signs of Bladder cancer. Signs and Symptoms of Bladder Cancer:
- Blood in the urine: .
- Urinary urgency or pain on urination
- Back or abdominal pain
- Loss of appetite and weight
- Uncontrollable Internal Bleeding,
- Brain hemorrhage
- Gastrointestinal system and GI tract bleeding
- Kidney bleeding
Nationwide Xarelto Lawyers Filing LawsuitsOur Nationwide Xarelto lawyers understand that you trusted your physician when they prescribed Xarelto. It was meant to protect your loved one from a stroke or other cardiac problem. But, the manufacturers of Xarelto were not upfront about the lack of an antidote for their product and it’s potential dangers. Call us and speak to an experienced dangerous drug lawyer. Our Xarelto lawyers have decades of experience.
U.S.A Xarelto Lawsuit
What is Pradaxa?
What Is Xarelto?Pradaxa is an anticoagulant used to prevent stroke in Cardiac patients. It is often used as an alternative to the medicine warfarin. If a person who is using Pradaxa requires unexpected surgery, from a fall for instance, the physician treating the patient may have a far more difficult time stopping serious bleeding, because the patient’s blood is unable to clot. Both Xarelto and Pradaxa can Cause excessive bleeding and a brain hemorrhage What Are the Symptoms of Brain Bleeding? The symptoms of a brain hemorrhage can vary. They depend on the location of the bleeding, the severity of the bleeding, and the amount of tissue affected. Symptoms may develop suddenly or over time.
- a sudden severe headache
- seizures with no previous history of seizures
- weakness in an arm or leg
- nausea or vomiting
- decreased alertness; lethargy
- changes in vision
- tingling or numbness
- difficulty speaking or understanding speech
- difficulty swallowing
- difficulty writing or reading
- loss of fine motor skills, such as hand tremors
- loss of coordination
- loss of balance
- an abnormal sense of taste
- loss of consciousness
- Unusual bruising or bleeding / hemorrhaging
- Pink or brown urine
- Red or black tarry stools
- Coughing up blood
- Vomiting that resembles blood or looks like coffee grounds
- Bleeding from the gums
- Frequent nosebleeds
- Joint pain or swelling
- Weakness and swelling of the arms, hands, feet, ankles or lower legs.
Lawyers investigating most serious side effects of Pradaxa including:
- death from severe or excessive bleeding
- gastrointestinal bleeding
- stomach pain (ulcers, nausea, heartburn, bloating)
- kidney failure (kidney bleeding)
- hemorrhagic stroke cerebral hemorrhage
- heart attack
- brain hemorrhaging
Pradaxa causes extensive bleeding. It is an anticoagulant with no antidote and can create complications in emergency surgery. Massachusetts Pradaxa lawyers filing lawsuits for Boston, Cape Cod, Springfield, Worcester and all of massachusetts regarding serious complications from Pradaxa extensive Bleeding. See the Boston Pradaxa Article Below which was found on line and being shared with our pradaxa Helpline readers.
HRS: To have or to hold—anticoagulation use during device procedure
BOSTON—To hold or not to hold, that may be the question on surgeons' minds as patients present for surgery. Should anticoagulation be continued at the time of surgery or held in fear of thromboembolic risk? According to Michael C. Giudici, MD, of Genesis Heart Institute in Davenport, Iowa, the complication risks may be similar for both options; however, he summed that in most cases anticoagulation can and should be continued.
Giudici, who presented his lecture May 11 at the 33rd annual scientific sessions of the Heart Rhythm Society, discussed the various management options for patients undergoing surgery, including how to manage anticoagulation use during device implantation.
“At our center, it was not uncommon for us to bring a patient in with uncontrollable atrial fibrillation [AF] … who needed a pacemaker device, etc.,” he said. “We noticed that we were seeing patients with INRs of 5.2, 3.6, etc.,” he said. “We never had any problems [when we continued anticoagulation]. These turned out to just be routine cases.”
After that, Giudici and his colleagues decided to look at whether anticoagulation should be continued or discontinued during a device implantation in a study that enrolled 1,025 patients (Pacing Clin Electrophysiol 2004;3:358-60). Patients were undergoing pacemaker or implantable cardioverter-defibrillator implantation. The researchers set out to determine whether anticoagulated patients required normalization of coagulation.
Of the patient cohort, 470 of those were on warfarin and had a high INR that was greater than 1.5 and 555 patients had an INR that was less than 1.5. These patients included those where warfarin had been discontinued or reversed and those who had no anticoagulant therapy or antiplatelet agents alone. “We found very few hematomas,” he said.
Giudici et al reported nine pocket hematomas. For the patients who went off anticoagulation during the study, one patient had a stroke. However, Giudici said there were no “significant complications reported one way or another.” Therefore, it was found that routine normalization of coagulation prior to device implant may not be necessary.
Other literature has looked at heparin bridging. Guidici referenced a heparin bridging study in which heparin was started either 12 hours post-procedure or the day after procedure. Results showed that 22 percent of patients who received heparin 12 hours post procedure experienced pocket hematomas compared with the 17 percent seen in patients who received heparin the next day.
“In low-risk patients there were no reported hematomas,” he said. However, in the heparin bridge group there was a rate of 13 percent. A study by Tomkins et al in 2009 found that dual-antiplatelet therapy and periprocedural heparin increased the risk of bleeding complications at the time of device implant (J Am Coll Cardiol 2010;55:2376-2382).
At Giudici’s practice, they looked carefully at pocket hematomas. He and colleagues referred to surgical literature to see what options were outlined. He said the literature read: “'In minor surgical procedures, anticoagulation need not to be discontinued,' and this is what we have seen in our practice.”
Giudici also touched on heparin use during AF ablation in patients who received dabigatran (Pradaxa, Boehringer Ingelheim) and warfarin. “We use a heck of a lot more heparin in patients on Pradaxa compared with those on warfarin,” he said. Additionally, he said dabigatran patients often see more groin complications.
“We want these patients anticoagulated,” he said. “We want them to have an INR because we use much less heparin and see much less groin complications when compared to those on dabigatran.”
For AF ablation at least, Giudici suggested attempting to keep patients on warfarin "whenever possible.”
He also referenced a European study that found similar results: that complication rates for patients who continued dabigatran during an AF ablation procedure were much higher.
Additionally, an audience member said that in a 404 patient study where half of patients were administered dabigatran and half warfarin during AF ablation, one patient on dabigatran had a “fairly spectacular bleed.”
While he added that tapenade bleeds on warfarin can usually be corrected, the bleed on dabigatran continued to leak so much that the patient lost over three liters of blood. Additionally, he said that more thromboembolic complications occurred (stroke and transient ischemic attack) in the dabiagtran patient group compared to those administered warfarin.
While Giudici alluded to the fact that anticoagulation should be continued during procedures, he said that warfarin patients may fare better in terms of bleeding and other risk factors.